Stock Earnings

Question 1

What are ANI Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), ANI Pharmaceuticals Inc has a total asset of $1,283, Net loss of $-20

Question 2

What are the key financial ratios for ANIP?

Accepted Answer

ANI Pharmaceuticals Inc's Current ratio is 1.5, has a Net margin is -3.25, sales per share of $31.78.

Question 3

How is ANI Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

ANI Pharmaceuticals Inc largest revenue segment is Generics and Other, at a revenue of 320,034,000 in the most earnings release.For geography, United States is the primary market for ANI Pharmaceuticals Inc, at a revenue of 604,989,000.

Question 4

Is ANI Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, ANI Pharmaceuticals Inc has a net loss of $-20

Question 5

Does ANI Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, ANI Pharmaceuticals Inc has liability of 855

Question 6

How many outstanding shares for ANI Pharmaceuticals Inc?

Accepted Answer

ANI Pharmaceuticals Inc has a total outstanding shares of 21.11

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	747	614	486	316	216	208
Revenue Growth (YoY)	11%	26%	54%	46%	4%	1%
Cost of Revenue	291	250	181	138	100	87
Gross Profit	456	364	305	177	115	121
Selling, General & Admin	307	249	161	124	84	65
Research & Development	53	44	34	22	11	16
Operating Expenses	433	361	257	207	143	125
Other Non Operating Income (Expenses)	-1	-4	0	0	-4	0
Pretax Income	-14	-22	19	-62	-56	-26
Income Tax Expense	-4	-3	1	-14	-13	-3
Net Income	-14	-20	15	-49	-42	-22
Net Income Growth	-135%	-233%	-131%	17%	91%	-467%
Shares Outstanding (Diluted)	20.3	19.31	18.19	16.3	12.6	12
Shares Change (YoY)	5%	6%	12%	28.99%	5%	0%
EPS (Diluted)	-0.7	-1.04	0.85	-3.05	-3.4	-1.88
EPS Growth	-133%	-222%	-128%	-10%	81%	-476%
Free Cash Flow	125	47	110	-40	0	9
Free Cash Flow Per Share	6.15	2.43	6.04	-2.45	0	0.75
Gross Margin	61.04%	59.28%	62.75%	56.01%	53.24%	58.17%
Operating Margin	2.94%	0.32%	9.87%	-9.17%	-12.5%	-1.92%
Profit Margin	-1.87%	-3.25%	3.08%	-15.5%	-19.44%	-10.57%
Free Cash Flow Margin	16.73%	7.65%	22.63%	-12.65%	0%	4.32%
EBITDA	106	69	107	30	20	40
EBITDA Margin	14.19%	11.23%	22.01%	9.49%	9.25%	19.23%
D&A For EBITDA	84	67	59	59	47	44
EBIT	22	2	48	-29	-27	-4
EBIT Margin	2.94%	0.32%	9.87%	-9.17%	-12.5%	-1.92%
Effective Tax Rate	28.57%	13.63%	5.26%	22.58%	23.21%	11.53%

ANI Pharmaceuticals Inc (ANIP) Price

ANIP Stock Price Chart

ANIP Income

Follow-Up Questions